OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 24
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 24
Showing 24 citing articles:
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers
Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1235-1235
Open Access | Times Cited: 3
Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1235-1235
Open Access | Times Cited: 3
Microenvironment-based immunotherapy in oral cancer: a comprehensive review
Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Masumeh Ghazanfarpour, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 2
Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, Masumeh Ghazanfarpour, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 2
The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations
Angela Santoro, Giuseppe Angelico, Frediano Inzani, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 57-66
Open Access | Times Cited: 14
Angela Santoro, Giuseppe Angelico, Frediano Inzani, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 57-66
Open Access | Times Cited: 14
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access | Times Cited: 1
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access | Times Cited: 1
DRG2 is required for surface localization of PD-L1 and the efficacy of anti-PD-1 therapy
Seong Hee Choi, Muralidharan Mani, Jeonghwan Kim, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Seong Hee Choi, Muralidharan Mani, Jeonghwan Kim, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Differentially Expressed MicroRNAs in Pre-Transplant Lung Biopsies Target Immune Checkpoint Proteins and can Predict Primary Graft Dysfunction in Lung Transplantation
Vitale Miceli, Pia Ferrigno, Claudio Centi, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42515-e42515
Open Access
Vitale Miceli, Pia Ferrigno, Claudio Centi, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42515-e42515
Open Access
Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
Pengliang Xu, Huanming Yu, Hongqiang Bian, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Pengliang Xu, Huanming Yu, Hongqiang Bian, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Molecular Mechanisms of Immune Regulation: A Review
Borros Arneth
Cells (2025) Vol. 14, Iss. 4, pp. 283-283
Open Access
Borros Arneth
Cells (2025) Vol. 14, Iss. 4, pp. 283-283
Open Access
The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges
Beilei Yue, Wenbo Gao, Jonathan F. Lovell, et al.
Essays in Biochemistry (2025) Vol. 69, Iss. 02
Open Access
Beilei Yue, Wenbo Gao, Jonathan F. Lovell, et al.
Essays in Biochemistry (2025) Vol. 69, Iss. 02
Open Access
Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys
Camila Canaan-Haden-Ayala, J. Sánchez-Ramírez, Rafael Martínez-Castillo, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 296-296
Open Access
Camila Canaan-Haden-Ayala, J. Sánchez-Ramírez, Rafael Martínez-Castillo, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 296-296
Open Access
State-of-the-Art Review on Liposomes as Versatile Cancer Vaccine Delivery Systems
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3
Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment
Manel Albertí‐Valls, S. Muntión Olave, Anna Olomí, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3918-3918
Open Access | Times Cited: 3
Manel Albertí‐Valls, S. Muntión Olave, Anna Olomí, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3918-3918
Open Access | Times Cited: 3
IL-17A/IL-17RA interaction blockade sensitizes synovial macrophages to efferocytosis and PD-L1 signaling via rewiring STAT-3/ADAM17/MERTK axis in rheumatoid arthritis animal model
Snigdha Samarpita, Susmita Srivastava, Manupati Srikanth, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112343-112343
Closed Access | Times Cited: 2
Snigdha Samarpita, Susmita Srivastava, Manupati Srikanth, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112343-112343
Closed Access | Times Cited: 2
IMMUNE EVASION IN CANCER IS REGULATED BY THE TUMOR-ASOCIATED MACROPHAGES (TAMS): TARGETING TAMS
Megan Jung, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 1-17
Closed Access | Times Cited: 1
Megan Jung, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 1-17
Closed Access | Times Cited: 1
Effects of temporal IFNγ exposure on macrophage phenotype and secretory profile: exploring GMP-Compliant production of a novel subtype of regulatory macrophages (MregIFNγ0) for potential cell therapeutic applications
Karina Zitta, Lars Hummitzsch, Frank Lichte, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Karina Zitta, Lars Hummitzsch, Frank Lichte, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
The PD-1/PD-L1 Gateway: Peripheral Immune Regulation in the Pathogenesis of Endometriosis
Małgorzata Sobstyl, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6775-6775
Open Access | Times Cited: 1
Małgorzata Sobstyl, Paulina Mertowska, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6775-6775
Open Access | Times Cited: 1
Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells
Xingyue Wang, Chengyu Zhang, Jiahong Su, et al.
Aging and Disease (2024)
Open Access | Times Cited: 1
Xingyue Wang, Chengyu Zhang, Jiahong Su, et al.
Aging and Disease (2024)
Open Access | Times Cited: 1
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Elevated PD-L1 and PECAM-1 as Diagnostic Biomarkers of Acute Rejection in Lung Transplantation
René Novysedlák, Ján Balko, J. Tavandžis, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
René Novysedlák, Ján Balko, J. Tavandžis, et al.
Transplant International (2024) Vol. 37
Open Access | Times Cited: 1
İmmün Toleransın Temel Düzenleyicisi: PD-1/PD-L1 Sinyal Yolağının Fizyolojik ve Patolojik Gebelikteki Rolü
Remziye Kendirci, Ertan Katırcı, Leyla Satı
TURKISH JOURNAL OF HEALTH AND SPORT (TJHS) (2024) Vol. 5, Iss. TJHS Vol 5 Issue 1, pp. 1-6
Open Access
Remziye Kendirci, Ertan Katırcı, Leyla Satı
TURKISH JOURNAL OF HEALTH AND SPORT (TJHS) (2024) Vol. 5, Iss. TJHS Vol 5 Issue 1, pp. 1-6
Open Access
Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor
Hailang Yang, Li Ma, Wen Deng, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access
Hailang Yang, Li Ma, Wen Deng, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access
Upregulation of PD-L1 contributes to improving the apoptosis of granulosa cells via the PI3K/AKT pathway in PCOS
Rui Han, Yuejie Zhu, X.-N. Zhang, et al.
Journal of Assisted Reproduction and Genetics (2024)
Open Access
Rui Han, Yuejie Zhu, X.-N. Zhang, et al.
Journal of Assisted Reproduction and Genetics (2024)
Open Access
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
Tao Chen, Wei Sun, Zuojun Xu
Frontiers in Immunology (2024) Vol. 15
Open Access
Tao Chen, Wei Sun, Zuojun Xu
Frontiers in Immunology (2024) Vol. 15
Open Access
